GlassScriptPhysician profile
Hannah Otte
NPI 1811589351
$541.94
in general payments reported to CMS, 2019-2025
13 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $303 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $95.98 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.87 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.36 | 2024-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $48.64 | 2024-2025 | Verquvo |
| Pfizer INC. | $46.53 | 2024-2025 | |
| Novo Nordisk INC | $42.27 | 2025 | Wegovy, Rybelsus, Ozempic |
| Kiniksa Pharmaceuticals International, Plc | $35.91 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $29.13 | 2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $27.15 | 2024 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $22.31 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Esperion Therapeutics, INC. | $15.60 | 2025 | Nexletol |
| Philips North America LLC | $14.99 | 2024 | (Ck4) Mcot |
| Abiomed | $13.20 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Otte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.